Immune Thrombocytopenia (ITP) research hub

A Study of Efgartigimod IV in Participants From 12 Years to Less Than 18 Years of Age With Chronic Immune Thrombocytopenia (ITP)

An Open-label Study of Povetacicept in Participants With Autoimmune Cytopenias

This study looks at a new medicine called povetacicept for adults with rare blood conditions like Immune Thrombocytopenia (ITP), Warm Autoimmune Hemolytic Anemia (wAIHA), and Cold Agglutinin Disease (CAD). Researchers want to see if it's safe and helps improve these conditions.